UL Solutions: Scanlon proposes $3.82M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UL Solutions Inc. (ULS) notice lists Jennifer Scanlon, identified as a director and officer, as proposing to sell 37,500 common shares, with an aggregate market value of $3,819,750 and an approximate sale date of July 1, 2026. Morgan Stanley Smith Barney LLC is named as broker.
The securities table lists 30,212 common shares acquired through previously exercised stock options on April 1, 2025, and 7,288 common shares acquired as restricted stock units on May 1, 2026. Separately, the remarks state that the securities to be sold were acquired upon prior stock-option exercises from April 1 through April 2, 2025. The notice also reports 12,500-share sales on May 1 and June 1, 2026, each identified as a 10b5-1 sale, with gross proceeds of $1,144,595.00 and $1,249,982.50, respectively. The plan adoption date is December 9, 2025.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units financial
Previously Exercised Stock Options financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Jennifer Scanlon’s recent ULS stock sales?
When was the Rule 10b5-1 plan for the ULS sales adopted?
AI-generated analysis. How Rhea-AI works. Not financial advice.